web analytics

Hansa Biopharma: Issue and re-purchase of class C shares for incentive programme

Lund, Sweden September 2, 2019. Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced today that by virtue of the authorisation by the annual general meeting held on 22 May 2019, the board of directors of Hansa Biopharma AB (publ) has resolved to issue and immediately thereafter re-purchase 715,910 class C shares. The shares are issued and re-purchased in accordance with the incentive programme LTIP 2019, which was adopted by the annual general meeting held on 22 May 2019.

Carnegie Investment Bank AB (publ) will subscribe for the

Source: Hansa Biopharma: Issue and re-purchase of class C shares for incentive programme

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.